Logo image of PATH

UIPATH INC - CLASS A (PATH) Stock Fundamental Analysis

USA - NYSE:PATH - US90364P1057 - Common Stock

16.48 USD
+1.04 (+6.74%)
Last: 10/24/2025, 8:04:01 PM
16.55 USD
+0.07 (+0.42%)
After Hours: 10/24/2025, 8:04:01 PM
Fundamental Rating

5

PATH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. No worries on liquidiy or solvency for PATH as it has an excellent financial health rating, but there are worries on the profitability. PATH is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PATH had positive earnings in the past year.
PATH had a positive operating cash flow in the past year.
In the past 5 years PATH always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: PATH reported negative operating cash flow in multiple years.
PATH Yearly Net Income VS EBIT VS OCF VS FCFPATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

PATH has a better Return On Assets (0.78%) than 62.81% of its industry peers.
PATH has a better Return On Equity (1.21%) than 63.86% of its industry peers.
Industry RankSector Rank
ROA 0.78%
ROE 1.21%
ROIC N/A
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
PATH Yearly ROA, ROE, ROICPATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

PATH has a better Profit Margin (1.35%) than 63.16% of its industry peers.
With an excellent Gross Margin value of 83.06%, PATH belongs to the best of the industry, outperforming 90.18% of the companies in the same industry.
In the last couple of years the Gross Margin of PATH has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 1.35%
GM 83.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
PATH Yearly Profit, Operating, Gross MarginsPATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

PATH does not have a ROIC to compare to the WACC, probably because it is not profitable.
PATH has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PATH has been increased compared to 5 years ago.
There is no outstanding debt for PATH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PATH Yearly Shares OutstandingPATH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
PATH Yearly Total Debt VS Total AssetsPATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

PATH has an Altman-Z score of 5.36. This indicates that PATH is financially healthy and has little risk of bankruptcy at the moment.
PATH's Altman-Z score of 5.36 is fine compared to the rest of the industry. PATH outperforms 70.53% of its industry peers.
PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.36
ROIC/WACCN/A
WACC11.03%
PATH Yearly LT Debt VS Equity VS FCFPATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.75 indicates that PATH has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.75, PATH is doing good in the industry, outperforming 75.44% of the companies in the same industry.
PATH has a Quick Ratio of 2.75. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.75, PATH is doing good in the industry, outperforming 76.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.75
PATH Yearly Current Assets VS Current LiabilitesPATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.53% over the past year.
PATH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 88.99% yearly.
The Revenue has grown by 8.25% in the past year. This is quite good.
PATH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.58% yearly.
EPS 1Y (TTM)23.53%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%275%
Revenue 1Y (TTM)8.25%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%14.38%

3.2 Future

The Earnings Per Share is expected to grow by 1.84% on average over the next years.
Based on estimates for the next years, PATH will show a quite strong growth in Revenue. The Revenue will grow by 11.61% on average per year.
EPS Next Y24.13%
EPS Next 2Y18.66%
EPS Next 3Y15.02%
EPS Next 5Y1.84%
Revenue Next Year9.93%
Revenue Next 2Y9.39%
Revenue Next 3Y8.79%
Revenue Next 5Y11.61%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PATH Yearly Revenue VS EstimatesPATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
PATH Yearly EPS VS EstimatesPATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

PATH is valuated quite expensively with a Price/Earnings ratio of 26.16.
Based on the Price/Earnings ratio, PATH is valued a bit cheaper than the industry average as 71.58% of the companies are valued more expensively.
PATH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.91.
PATH is valuated rather expensively with a Price/Forward Earnings ratio of 21.67.
PATH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PATH is cheaper than 75.09% of the companies in the same industry.
PATH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.16
Fwd PE 21.67
PATH Price Earnings VS Forward Price EarningsPATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

75.09% of the companies in the same industry are more expensive than PATH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 28.26
EV/EBITDA N/A
PATH Per share dataPATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PATH's earnings are expected to grow with 15.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.08
PEG (5Y)N/A
EPS Next 2Y18.66%
EPS Next 3Y15.02%

0

5. Dividend

5.1 Amount

PATH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UIPATH INC - CLASS A

NYSE:PATH (10/24/2025, 8:04:01 PM)

After market: 16.55 +0.07 (+0.42%)

16.48

+1.04 (+6.74%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)12-03 2025-12-03/amc
Inst Owners82.05%
Inst Owner Change-0.06%
Ins Owners9.51%
Ins Owner Change4.77%
Market Cap8.75B
Revenue(TTM)1.50B
Net Income(TTM)20.17M
Analysts65.52
Price Target13.32 (-19.17%)
Short Float %13.39%
Short Ratio2.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.52%
Min EPS beat(2)7.36%
Max EPS beat(2)83.69%
EPS beat(4)4
Avg EPS beat(4)41.39%
Min EPS beat(4)7.36%
Max EPS beat(4)83.69%
EPS beat(8)8
Avg EPS beat(8)37.53%
EPS beat(12)12
Avg EPS beat(12)102.79%
EPS beat(16)16
Avg EPS beat(16)96.54%
Revenue beat(2)2
Avg Revenue beat(2)3.57%
Min Revenue beat(2)2.11%
Max Revenue beat(2)5.03%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)5.03%
Revenue beat(8)6
Avg Revenue beat(8)1.29%
Revenue beat(12)9
Avg Revenue beat(12)2.25%
Revenue beat(16)13
Avg Revenue beat(16)2.53%
PT rev (1m)-0.48%
PT rev (3m)-6.35%
EPS NQ rev (1m)4.16%
EPS NQ rev (3m)26.09%
EPS NY rev (1m)20.95%
EPS NY rev (3m)20.95%
Revenue NQ rev (1m)-1.08%
Revenue NQ rev (3m)1.98%
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)1.39%
Valuation
Industry RankSector Rank
PE 26.16
Fwd PE 21.67
P/S 5.85
P/FCF 28.26
P/OCF 26.14
P/B 5.25
P/tB 5.74
EV/EBITDA N/A
EPS(TTM)0.63
EY3.82%
EPS(NY)0.76
Fwd EY4.61%
FCF(TTM)0.58
FCFY3.54%
OCF(TTM)0.63
OCFY3.83%
SpS2.82
BVpS3.14
TBVpS2.87
PEG (NY)1.08
PEG (5Y)N/A
Graham Number6.67
Profitability
Industry RankSector Rank
ROA 0.78%
ROE 1.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.35%
GM 83.06%
FCFM 20.69%
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
F-Score7
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 164.78%
Cap/Sales 1.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 1535.31%
Current Ratio 2.75
Quick Ratio 2.75
Altman-Z 5.36
F-Score7
WACC11.03%
ROIC/WACCN/A
Cap/Depr(3y)82.11%
Cap/Depr(5y)72.19%
Cap/Sales(3y)1.29%
Cap/Sales(5y)1.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.53%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%275%
EPS Next Y24.13%
EPS Next 2Y18.66%
EPS Next 3Y15.02%
EPS Next 5Y1.84%
Revenue 1Y (TTM)8.25%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%14.38%
Revenue Next Year9.93%
Revenue Next 2Y9.39%
Revenue Next 3Y8.79%
Revenue Next 5Y11.61%
EBIT growth 1Y83.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.52%
EBIT Next 3Y28.48%
EBIT Next 5Y22.63%
FCF growth 1Y84.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.85%
OCF growth 3YN/A
OCF growth 5YN/A

UIPATH INC - CLASS A / PATH FAQ

What is the fundamental rating for PATH stock?

ChartMill assigns a fundamental rating of 5 / 10 to PATH.


Can you provide the valuation status for UIPATH INC - CLASS A?

ChartMill assigns a valuation rating of 4 / 10 to UIPATH INC - CLASS A (PATH). This can be considered as Fairly Valued.


How profitable is UIPATH INC - CLASS A (PATH) stock?

UIPATH INC - CLASS A (PATH) has a profitability rating of 3 / 10.


How financially healthy is UIPATH INC - CLASS A?

The financial health rating of UIPATH INC - CLASS A (PATH) is 8 / 10.